ALISKIREN HEMIFUMARATE | API DMFs | US Drug Master File (DMF) Details | Pharmacompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

ALISKIREN HEMIFUMARATE
USDMF

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

With Fermion, start the journey of your innovative API.

Contact Supplier

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

ALISKIREN HEMIFUMARATE

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

8 API Suppliers, 4 USDMF, 3 EU WC, 3 NDC API, 4 Listed Suppliers

8 API Suppliers
4 USDMF
3 EU WC
3 NDC API
4 Listed Suppliers

INTERMEDIATES

5 Intermediates Suppliers

5 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

24 FDF Dossiers, 20 FDA Orange Book, 4 Europe

24 FDF Dossiers
20 FDA Orange Book
4 Europe

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 150MG BASE, TABLET;ORAL - EQ 300MG BASE, TABLET;ORAL - EQ 150MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 150MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 300MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 300MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 150MG BASE, TABLET;ORAL - EQ 300MG BASE, TABLET;ORAL - EQ 150MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 150MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 300MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 300MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 150MG BASE
TABLET;ORAL - EQ 300MG BASE
TABLET;ORAL - EQ 150MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 150MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 300MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 300MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 150MG BASE
TABLET;ORAL - EQ 300MG BASE
TABLET;ORAL - EQ 150MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 150MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 300MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 300MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 2 Seqens, 4 DKSH, 2 Faran Shimi Pharmaceutical, 5 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 1 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 22 BASF, 10 Corel Pharma Chem, 2 DFE Pharma, 1 Finar, 8 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 16 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 2 Nomisma Healthcare, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 2 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 10 Roquette, 6 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

44 Coating Systems & Additives, 33 Fillers, Diluents & Binders, 28 Controlled & Modified Release, 24 Direct Compression, 19 Thickeners and Stabilizers, 18 Disintegrants & Superdisintegrants, 17 Granulation, 13 Solubilizers, 13 Lubricants & Glidants, 11 Co-Processed Excipients, 8 Film Formers & Plasticizers, 7 Topical, 6 Chewable & Orodispersible Aids, 5 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Taste Masking, 4 Emulsifying Agents, 4 Parenteral, 2 Rheology Modifiers

44 Coating Systems & Additives
33 Fillers, Diluents & Binders
28 Controlled & Modified Release
24 Direct Compression
19 Thickeners and Stabilizers
18 Disintegrants & Superdisintegrants
17 Granulation
13 Solubilizers
13 Lubricants & Glidants
11 Co-Processed Excipients
8 Film Formers & Plasticizers
7 Topical
6 Chewable & Orodispersible Aids
5 Empty Capsules
5 Coloring Agents
4 Vegetarian Capsules
4 API Stability Enhancers
4 Taste Masking
4 Emulsifying Agents
4 Parenteral
2 Rheology Modifiers

DIGITAL CONTENT

13 NEWS #PharmaBuzz

13 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 4 Finished Drug Prices, 1 Annual Reports

3 US Medicaid Prescriptions
4 Finished Drug Prices
1 Annual Reports

MARKET PLACE

1 APIs, 1 FDF Dossiers

1 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

14 US Patents, 2 Health Canada Patents

14 US Patents
2 Health Canada Patents

Xls

Filters

Reset all filters

Filters

FILTER :

filter Holder Reset all filters

4 All

01 1CHEMO IBERICA SA

02 1Changzhou Pharmaceutical Factory

03 1Jubilant Generics

04 1MSN Laboratories

filter Subject Reset all filters

4 All

01 3ALISKIREN HEMIFUMARATE

02 1ALISKIREN HEMIFUMARATE [ROUTE CODE - "AF"]

filter Country Reset all filters

4 All

01 1China

02 2India

03 1Spain

filter Status Reset all filters

4 All

01 2Active

02 2Inactive

filter GDUFA DMF Review Reset all filters

4 All

01 1Complete

02 3Blank

List of Suppliers

Product Main Page

01

Changzhou Pharmaceutical Factory

USDMF

Antibody Engineering

Not Confirmed

01

Changzhou Pharmaceutical Factory

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Aliskiren Hemifumarate

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 24755

Submission : 2011-03-10

Status : Inactive

Type : II

Product Web Link

Digital Content

02

Chemo Iberica Sa

USDMF

Antibody Engineering

Not Confirmed

02

Chemo Iberica Sa

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Aliskiren Hemifumarate

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 26776

Submission : 2012-12-27

Status : Inactive

Type : II

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Jubilant Pharmova Ltd

USDMF

Antibody Engineering

Not Confirmed

03

Jubilant Pharmova Ltd

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Aliskiren Hemifumarate

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 28050

Submission : 2014-03-31

Status : Active

Type : II

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Msn Laboratories Private Ltd

USDMF

Antibody Engineering

Not Confirmed

04

Msn Laboratories Private Ltd

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Aliskiren Hemifumarate [route Code - "af"]

GDUFA

DMF Review : Complete

Rev. Date : 2015-10-23

Pay. Date : 2015-09-18

DMF Number : 26975

Submission : 2013-04-29

Status : Active

Type : II

Product Web Link

Digital Content

Corporate PDF

ALISKIREN HEMIFUMARATE Manufacturers | Traders | Suppliers

ALISKIREN HEMIFUMARATE Manufacturers, Traders, Suppliers 1

47

We have 4 companies offering ALISKIREN HEMIFUMARATE

Get in contact with the supplier of your choice:

Changzhou Pharmaceutical Factory
CHEMO IBERICA SA
Jubilant Generics
MSN Laboratories

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?